Fast Forward Medical Innovation (FFMI) offers funding, education, and business development resources to help biomedical researchers navigate the road to successful innovation and commercialization.
From entrepreneurial organizations on campus to partners in Michigan and across the globe, we are creating an environment and culture that nurtures technologies and supports life sciences. The ultimate goal of our research is for it to impact patients and their families.
We invite you click on the image to the left to view our latest annual report. Below are metrics that provide a snapshot of biomedical commercialization activities for the U-M Medical School’s fiscal year 2022.
Interested in a broader view of research at the University of Michigan Medical School? CLICK HERE to view the 2022 U-M Medical School Office of Research Annual Report.
Industry Research Awards
New Business Startups
Industry Award Count
awarded to date for teams that have gone through an FFMI education program
Commercialization Education Programs
serving biomedical innovators across the University of Michigan, and across the state, region, and nation
enrolled in Commercialization Education programs, to date
describing best practice for Commercialization Education programs
from project teams at U-M and across the nation
across the state, region, and nation (outside of the University of Michigan) that have participated in FFMI fastPACE
MICHIGAN BIOMEDICAL VENTURE FUND
funded since launch
12 out of 13
have received follow-on funding/co-investments, (1 exited)
$30+ of Follow-On Funding
for every $1 of Michigan Biomedical Venture Fund investment
for all companies combined
in 13 companies